Company Filing History:
Years Active: 1986-2005
Title: **Innovative Contributions of Glenn H Kawasaki**
Introduction
Glenn H Kawasaki is a distinguished inventor based in Seattle, WA. With an impressive portfolio of 14 patents, he has made significant contributions to the field of enzymatic assays, particularly regarding homocysteine and cystathionine. His innovative work continues to impact the medical and scientific communities, enhancing methods for assessing critical biomarkers in biological samples.
Latest Patents
One of Glenn H Kawasaki's latest patents is titled "Enzymatic cycling assays for homocysteine and cystathionine." This invention presents a novel enzymatic cycling assay designed to assess the amounts of homocysteine and cystathionine in various solutions, including blood and urine. The assay unfolds through a series of steps, involving the creation of a reaction mixture that includes CBS (cystathionine beta-synthase), L-serine, and CBL (cystathionine lyase). This process catalyzes the cyclical conversion between homocysteine and cystathionine while releasing pyruvate and ammonia. The amount of these substances formed is then used to determine the concentration of homocysteine and/or cystathionine in the original solution. Notably, this assay can be conducted in 15 minutes or less, utilizing a minimal amount of enzymes, which adds to its efficiency and applicability in clinical settings.
Career Highlights
Throughout his career, Glenn H Kawasaki has been associated with prominent companies like Zymogenetics, Inc. and Catch, Inc. His work at these organizations has allowed him to develop and refine his innovative assays, contributing to advancements in diagnostic technologies.
Collaborations
Glenn has collaborated with esteemed colleagues, including Leslie Bell and Heather Kay Webb. These collaborations have further enriched his research endeavors, leading to the successful development of new technologies and enhancing the capabilities of existing assays.
Conclusion
Glenn H Kawasaki is a notable figure in the realm of medical innovations, particularly through his pioneering work on enzymatic cycling assays. His contributions not only provide valuable tools for the assessment of critical health markers but also reflect the ongoing advancements in the field of biotechnology. As he continues to innovate, the impact of his inventions is sure to extend within the scientific community and beyond, enhancing diagnostic methodologies for years to come.